ELINORE MCCANCE-KATZ

• Born:
• Nationality: Ameriican
• Profession: Physician & Health Administrator

She is the U, S, Assistant Secretary of Health for Mental Health & Substance Abuse She was a Professor at Brown Univsity Medical School, and the Commissioner of Mental Health for Rhode Island Dr. McCance-Katz also served at the University of California San Francisco where she was a Professor of Psychiatry and was the State Medical Director for the California Department of Alcohol and Drug Programs. She is board-certified in General Psychiatry and Addiction Psychiatry and is a Distinguished Fellow of the American Academy of Addiction Psychiatry. Dr. McCance-Katz has been working in the field of addiction medicine for 22 years as a clinician, teacher, and clinical researcher. Her specialty areas include pharmacotherapy for substance use disorders, clinical pharmacology of drugs of abuse, drug interactions, cocaine/alcohol/opioid medications development, and co-occurring HIV disease and addiction. Her clinical interests are in the treatment of those with co-occurring substance use disorders, infectious diseases including HIV and HCV, and mental illness. She is also interested in the treatment of those with chronic pain who have developed problems with opioid analgesic overuse/misuse often with co-occurring mental illness. Dr. McCance-Katz worked on several SAMHSA projects prior to coming to SAMHSA as the Chief Medical Officer. She was the Medical Director of the Physicians’ Clinical Support System for Buprenorphine and the Prescribers’ Clinical Support System for Opioid Therapies which are Center for Substance Abuse Treatment (CSAT)/SAMHSA-sponsored national training and peer support programs for physicians and clinicians treating patients with clinical need for opioid medications. Dr. McCance-Katz has also helped to develop educational curricula to assist with the integration of substance use screening, brief intervention and treatment referral into primary care settings through an SBIRT grant to UCSF. Internationally, she has been part of a World Health Organization (WHO) committee to develop guidelines on the treatment of drug users living with HIV/AIDS and has reviewed and contributed to WHO white papers on methadone and buprenorphine treatment of opiate addiction. She participated in the President’s Emergency Program for AIDS Relief (PEPFAR) where she assisted with the development of methadone maintenance programs in Vietnam. Most recently, Dr. McCance-Katz has conducted studies of drug-drug interactions between opioids or alcohol and HIV therapeutics through research studies funded by NIAAA/NIH and drug interactions between disulfiram and HIV therapeutics funded by NIDA/NIH.